Wentao Bo

Chengdu, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

NAT10 as a central node in cancer biology: integrating epitranscriptomic regulation, metabolic reprogramming, and immune modulation.

NAT10 as a central node in cancer biology: integrating epitranscriptomic regulation, metabolic reprogramming, and immune modulation.

Journal: Frontiers in immunology
Published: April 01, 2026

HNRNPA2B1 as an emerging coordinator of RNA fate in cancer: m6A reading, RNA export, translation reprogramming, and immune-metabolic adaptation.

HNRNPA2B1 as an emerging coordinator of RNA fate in cancer: m6A reading, RNA export, translation reprogramming, and immune-metabolic adaptation.

Journal: Frontiers in immunology
Published: February 06, 2026

The Association Between Inclusive Leadership and Job Performance in Nurses: Exploring the Mediation Roles of Grit and Work Engagement Based on a Cross-Sectional Study.

The Association Between Inclusive Leadership and Job Performance in Nurses: Exploring the Mediation Roles of Grit and Work Engagement Based on a Cross-Sectional Study.

Journal: Journal of nursing management
Published: September 27, 2025

Systematic review of the efficacy and safety of lenvatinib vs. sorafenib as first-line treatments for hepatocellular carcinoma.

Systematic review of the efficacy and safety of lenvatinib vs. sorafenib as first-line treatments for hepatocellular carcinoma.

Journal: Clinics (Sao Paulo, Brazil)
Published: May 08, 2025

Neoadjuvant therapy with triple therapy for centrally located hepatocellular carcinoma.

Neoadjuvant therapy with triple therapy for centrally located hepatocellular carcinoma.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: December 07, 2024

Progress and application of lung-on-a-chip for lung cancer.

Progress and application of lung-on-a-chip for lung cancer.

Journal: Frontiers in bioengineering and biotechnology
Published: February 02, 2024

Strategies and Recent Advances on Improving Efficient Antitumor of Lenvatinib Based on Nanoparticle Delivery System.

Strategies and Recent Advances on Improving Efficient Antitumor of Lenvatinib Based on Nanoparticle Delivery System.

Journal: International journal of nanomedicine
Published: January 23, 2024

Upregulation of HSD11B1 promotes cortisol production and inhibits NK cell activation in pancreatic adenocarcinoma.

Upregulation of HSD11B1 promotes cortisol production and inhibits NK cell activation in pancreatic adenocarcinoma.

Journal: Molecular immunology
Published: January 21, 2024

Lenvatinib resistance mechanism and potential ways to conquer.

Lenvatinib resistance mechanism and potential ways to conquer.

Journal: Frontiers in pharmacology
Published: January 30, 2023

Overexpression of rhophilin 2 promotes pancreatic ductal adenocarcinoma.

Overexpression of rhophilin 2 promotes pancreatic ductal adenocarcinoma.

Journal: Oncology letters
Published: May 13, 2020

Overexpression of Rhophilin Rho GTPase-binding protein 2 promotes hepatocellular carcinoma.

Overexpression of Rhophilin Rho GTPase-binding protein 2 promotes hepatocellular carcinoma.

Journal: Oncology letters
Published: April 16, 2020

Long non-coding RNA CASC2 upregulates PTEN to suppress pancreatic carcinoma cell metastasis by downregulating miR-21.

Long non-coding RNA CASC2 upregulates PTEN to suppress pancreatic carcinoma cell metastasis by downregulating miR-21.

Journal: Cancer cell international
Published: September 07, 2018
Showing 1-12 of 19

Last Updated: 09/26/2026